Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
View specifications & research profile Per vial Research use only COA available Free UK delivery A prepared 3ml refill-cartridge presentation for the same documented research context as the dsip powder vial
Combination safety profile No documented adverse interactions between BPC-157 and TB-500 emerge from available research or community experience
Common adverse reactions include local injection-site discomfort, redness, or swelling
Clinically relevant 50 mg strength High-purity pharmaceutical-grade compound Backed by preclinical metabolic science Integrates well with NAD optimization and fat-loss regimens No known hormonal effects
Abortive infections have been identified in seronegative individuals, a status confirmed with multiple spike and nucleoprotein sero-assays as well as pseudovirus neutralization
US$ 22.36
US$ 29.32
US$ 21.41
US$ 28.27
US$ 21.44
